
We encourage
you to discuss Functional Tumor Cell Profiling openly with your doctor.
After all, he or she will be the one to administer and monitor the
treatment which is based upon your Functional Tumor Cell Profiling test
results. Most cancer physicians
are pleased for their patients to take an active role in managing their own
illnesses. You and your doctor
can be an effective team when you work together.
Much progress
has been made in cancer management over the past 20 years and Functional
Tumor Cell Profiling is no different.
Your doctor might not be aware that Functional Tumor Cell Profiling
can be helpful beyond what he or she already knows about choosing drugs -
or, he or she may have knowledge of other types of chemotherapy drug
sensitivity tests that were applied over the years by different
laboratories. Most testing
methods of just a few years ago are no longer used.
The newer and vastly improved methods that are in use today,
especially those used by the Weisenthal Cancer Group, have undergone
rigorous scrutiny in dozens of different studies performed by independent
researchers and published in peer-reviewed medical journals.
We would like for you and your physician to understand exactly what
level of proof now exists that shows how Functional Tumor Cell Profiling can
be useful in making treatment decisions.
Just as importantly, we would also like for your physician to
understand exactly how to use the information provided by your tests to the
best possible advantage once it is obtained for you.
Larry Weisenthal,
M.D., Ph.D.
is a medical doctor who is board certified in internal medicine and medical
oncology and is Associate Professor of Clinical Medicine at the
(714) 596-2100 Dr. Weisenthal
consultation hours for physicians: 11 AM - 5 PM Pacific
